Literature DB >> 16525500

Risk score model for fatal intracranial hemorrhage in acute leukemia.

H Kim1, J-H Lee, S-J Choi, J-H Lee, M Seol, Y S Lee, W-K Kim, J-S Lee, K-H Lee.   

Abstract

To build a risk score (RS) model of fatal intracranial hemorrhage (FICH) in patients with acute leukemia, we retrospectively assessed risk factors in 792 patients newly diagnosed with acute leukemia, 41 of whom had analyzable FICH. We found that female gender (relative risk (RR) = 5.234, P<0.001), acute promyelocytic leukemia (RR = 4.057, P = 0.003), leukocytosis (RR = 3.301, P = 0.004), thrombocytopenia (RR = 3.283, P = 0.005) and prolonged prothrombin time (RR = 3.291, P = 0.016) were significantly associated with occurrence of FICH in multivariate analysis. To calculate RS for FICH, one point was assigned for each risk factor, making the RS between 0 and 5. The RS model segregated patients into three prognostic groups: a low-risk group (LRG) for RS of 0 or 1; an intermediate-risk group (IRG) for RS of 2 or 3; and a high-risk group (HRG) for RS of 4 or 5. Expectation of FICH was well correlated with risk groups (all P-values < 0.001). Overall survival was significantly shorter in the HRG compared with the LRG. The RS model we constructed to predict the occurrence of FICH will be verified through prospective studies.

Entities:  

Mesh:

Year:  2006        PMID: 16525500     DOI: 10.1038/sj.leu.2404148

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  10 in total

1.  Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia.

Authors:  Kunimoto Ichikawa; Yoko Edahiro; Akihiko Gotoh; Kazuhide Iiduka; Norio Komatsu; Michiaki Koike
Journal:  Int J Hematol       Date:  2016-07-25       Impact factor: 2.490

Review 2.  Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies.

Authors:  Takayuki Ikezoe
Journal:  Int J Hematol       Date:  2020-09-09       Impact factor: 2.490

3.  Spontaneous intracranial haemorrhage in critically ill patients with malignancies.

Authors:  Jeong-Am Ryu; Daesang Lee; Jeong Hoon Yang; Chi-Ryang Chung; Chi-Min Park; Gee Young Suh; Kyeongman Jeon
Journal:  Support Care Cancer       Date:  2016-02-11       Impact factor: 3.603

4.  Prediction model for mortality after intracranial hemorrhage in patients with leukemia.

Authors:  Farshid Dayyani; Sarah Schellhorn Mougalian; Kiran Naqvi; Jianqin Shan; Farhad Ravandi; Jorge Cortes; Jeffrey Weinberg; Elias Jabbour; Stefan Faderl; William Wierda; Deborah Thomas; Susan O'Brien; Sherry Pierce; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Am J Hematol       Date:  2011-04-20       Impact factor: 10.047

5.  Intracranial hemorrhage in adult patients with hematological malignancies.

Authors:  Chien-Yuan Chen; Chan-Hwei Tai; Aristine Cheng; Hung-Chang Wu; Woei Tsay; Jia-Hau Liu; Pey-Ying Chen; Shang-Yi Huang; Ming Yao; Jih-Luh Tang; Hwei-Fang Tien
Journal:  BMC Med       Date:  2012-08-29       Impact factor: 8.775

Review 6.  Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation.

Authors:  Duccio Maria Cordelli; Riccardo Masetti; Daniele Zama; Francesco Toni; Ilaria Castelli; Emilia Ricci; Emilio Franzoni; Andrea Pession
Journal:  Front Pediatr       Date:  2017-05-15       Impact factor: 3.418

7.  Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia - a nested case-control study.

Authors:  Loes L Cornelissen; Aukje L Kreuger; Camila Caram-Deelder; Rutger A Middelburg; Jean Louis H Kerkhoffs; Peter A von dem Borne; Erik A M Beckers; Karen M K de Vooght; Jürgen Kuball; J J Zwaginga; Johanna G van der Bom
Journal:  Ann Hematol       Date:  2020-10-17       Impact factor: 3.673

8.  Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy.

Authors:  Jurjen Versluis; Manu Pandey; Yael Flamand; J Erika Haydu; Roger Belizaire; Mark Faber; Rahul S Vedula; Anne Charles; Kevin M Copson; Shai Shimony; Alon Rozental; Pavan K Bendapudi; Ofir Wolach; Elizabeth A Griffiths; James E Thompson; Richard M Stone; Daniel J DeAngelo; Donna Neuberg; Marlise R Luskin; Eunice S Wang; R Coleman Lindsley
Journal:  Blood Adv       Date:  2022-05-10

9.  Analysis of Risk Factors of Coagulation Dysfunction and Hemorrhage in Newly Diagnosed Hyperleukocytic Acute Myeloma Leukemia.

Authors:  Anjie Xu; Pan Liu; Fuling Zhou
Journal:  Contrast Media Mol Imaging       Date:  2022-07-13       Impact factor: 3.009

10.  Severe Intracranial Hemorrhage at Initial Presentation of Acute Myelogenous Leukemia.

Authors:  Amanda Balmages; Joseph Dinglasan; Megan Boysen Osborn
Journal:  Clin Pract Cases Emerg Med       Date:  2018-06-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.